NYSE:CNC
Centene Corporation Stock News
$74.33
+2.11 (+2.92%)
At Close: May 02, 2024
Buy These 5 Price-to-Book Value Stocks for Gains in 2024
08:16am, Tuesday, 09'th Jan 2024
The P/B ratio helps to identify low-priced stocks with high growth prospects. General Motors Company (GM), Park Hotels & Resorts (PK), Qifu Technology (QFIN), Centene (CNC) and Deutsche Bank Aktienges
Here's Why You Should Retain Centene (CNC) Stock For Now
03:47pm, Friday, 29'th Dec 2023
Centene (CNC) remains well-poised for growth on the back of overall membership growth, acquisitions, business streamlining efforts and a growing cash balance.
CENTENE TO PRESENT AT 42ND ANNUAL J. P. MORGAN HEALTHCARE CONFERENCE
08:30am, Friday, 22'nd Dec 2023
ST. LOUIS , Dec. 22, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the 42nd Annual J. P. Morgan Healthcare Conference, to be held Monday, January 8 – Thurs
4 Low Price-to-Cash Flow Stocks to Navigate the Market in 2024
11:17am, Thursday, 21'st Dec 2023
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Park Hotels & Resorts (PK), Centene (CNC), Solo Brands (DTC) and AZZ Inc. (AZZ) boast low P/CF rat
4 Low Price-to-Book Stocks to Buy in the New Year
09:02am, Thursday, 21'st Dec 2023
The P/B ratio helps to identify low-priced stocks with high growth prospects. Solo Brands (DTC), Park Hotels & Resorts (PK), Centene (CNC) and Deluxe Corporation (DLX) are some such stocks.
4 Health Insurers Likely to Maintain Winning Streak in 2024
12:02pm, Tuesday, 19'th Dec 2023
Medical-HMO stocks like UNH, HUM, CNC and MOH are expected to reap the benefits of an aging U.S. population and growing premiums in 2024. However, challenges related to the resumption of elective proc
Here's Why Centene (CNC) is a Strong Value Stock
11:17am, Monday, 18'th Dec 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Centene (CNC) Stock?
11:19am, Friday, 15'th Dec 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Centene (CNC) Ties Up to Aid Its Marketplace Members in Chicago
01:32pm, Thursday, 14'th Dec 2023
Centene's (CNC) product - Ambetter of Illinois - along with RUSH aim to provide improved access to quality healthcare services for CNC's members in Chicago, and thereby grow its Marketplace business.
Centene (CNC) Unveils its 2024 Projections: Key Takeaways
09:03am, Wednesday, 13'th Dec 2023
Centene's (CNC) board boosts its share buyback program with a new $4 billion fund.
Centene Climbs After Raising Its Outlook as It Cut Costs and Boosting Its Stock Buyback
05:00pm, Tuesday, 12'th Dec 2023
Centene (CNC) shares gained close to 3% Tuesday after the health care provider raised its guidance as it cut costs, and boosted its stock buyback program.
Centene has helped Medicaid members move to marketplace products, says CEO Sarah London
02:51pm, Tuesday, 12'th Dec 2023
Sarah London, Centene CEO, and CNBC's Bertha Coombs join 'The Exchange' to discuss the company's investor day, the outlook for Medicare and Medicaid, and more.
Midday Movers: Centene Rises as Costs Fall, Oracle Tumbles on Cloud Sales Miss
01:40pm, Tuesday, 12'th Dec 2023
U.S. equities were slightly higher at midday as the latest report on consumer prices showed headline inflation easing ahead of tomorrow's decision from the Federal Reserve on interest rates in the pol
5 Value Stocks With Impressive EV-to-EBITDA Ratios to Snap Up
07:31am, Tuesday, 12'th Dec 2023
We have screened value stocks JAKK, JKS, CNC, ADT and CSR based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Centene's stock rises 1.4% premarket after managed care company offers guidance that's above consensus
06:13am, Tuesday, 12'th Dec 2023
Centene Corp.'s stock CNC, +0.65% rose 1.4% premarket Tuesday, after the managed care provider set guidance for 2024 that was above consensus, while backing higher-than-expected profit guidance for 20